GainPep, Inc. is an early-stage drug development company.

Our research focuses on the powerful wound-healing drug candidate fibroblast growth factor-peptide (FGF-P) and its derivatives. This agent will allow for many marketing opportunities, ranging from biosecurity to basic research to bone marrow transplantation to tissue engineering.

FGF-P has the potential to become the most effective and safest wound-healing drug on the market.

Paul OkunieffM.D.
Photo of Paul Okunieff

Recent Publications and Presentations